Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:01 am Sale |
2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 1,026,324 2.200% |
-1,156,840 (-52.99%) |
Filing History |
| 2024-10-22 4:06 pm Purchase |
2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX |
Jacobs Paul Anthony | 2,800,000 6.000% |
300,000 (+12.00%) |
Filing History |
| 2024-02-14 1:58 pm Purchase |
2023-12-31 | 13G | Nuo Therapeutics, Inc. AURX |
Jacobs Paul Anthony | 2,500,000 5.650% |
2,500,000 (New Position) |
Filing History |
| 2024-02-12 5:33 pm Sale |
2023-12-31 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 2,183,164 5.160% |
-516,836 (-19.14%) |
Filing History |
| 2023-12-20 2:18 pm Sale |
2023-12-18 | 13D | Nuo Therapeutics, Inc. AURX |
Pittman Scott M. | 5,401,054 12.100% |
-519,301 (-8.77%) |
Filing History |
| 2022-07-05 08:02 am Purchase |
2020-10-05 | 13D | Nuo Therapeutics, Inc. AURX |
SHEEDY CHARLES E | 13,098,497 39.000% |
1,908,820 (+17.06%) |
Filing History |
| 2022-07-05 08:01 am Purchase |
2020-10-05 | 13D | Nuo Therapeutics, Inc. AURX |
Pittman Scott M. | 5,920,355 18.600% |
1,814,555 (+44.19%) |
Filing History |
| 2022-07-05 08:01 am Purchase |
2020-10-05 | 13D | Nuo Therapeutics, Inc. AURX |
JORDEN DAVID EMERSON | 2,809,740 8.900% |
2,809,740 (New Position) |
Filing History |
| 2020-10-09 3:29 pm Purchase |
2020-10-05 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 2,700,000 9.240% |
2,700,000 (New Position) |
Filing History |